Animal evidence (22) suggested that liraglutide mitigated periodontal inflammation and oxidative stress by activating the Nrf2/HO-1 pathway, pointing to a mechanistic role for GLP-1 in obesity-related periodontal disease. This evidence concerns the gene HMOX1 and obesity due to melanocortin 4 receptor deficiency.